Daily aspirin could boost survival rates from head and neck cancer by up to 78%
[ad_1] Daily aspirin could boost survival rates from head and neck cancer by up to 78%Researchers at the University of California San Francisco looked at five-year survival rates for people diagnosed with the diseaseThey found a third or more patients benefited from the pillBy Press Association Published: 09:02 EST, 25 January 2019 | Updated: 10:03 EST, 25 January 2019 Regular use of aspirin or ibuprofen could dramatically boost survival from head and neck...